Concepedia

Author

Corrado Tarella

Azienda Ospedaliero Universitaria San Giovanni BattistaORCID

Also Known As

C Tarella, C. Tarella, Corrado Tarella, Gallamini, Andrea, Giuseppe Tarantini, R Lemoli

390

Publications

10.2K

Citations

52

H-Index

134

Concepts

All Affiliations

Azienda Ospedaliero Universitaria San Giovanni BattistaUniversity of TurinFondazione IRCCS Istituto Nazionale dei TumoriUniversity of MilanIstituti di Ricovero e Cura a Carattere Scientifico
CT

About

Corrado Tarella is an author at Azienda Ospedaliero Universitaria San Giovanni Battista specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

37

70

4.2K

2

Health Sciences

24

34

1.8K

3

Engineering

2

2

81

4

Social Sciences

1

1

26

5

Allergy

1

1

12

Corrado Tarella

×

135

Publications

9.3K

Citations

51

H-Index

YearCitations

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

AlessandroM. Gianni, Marco Bregni, A. Stern,

The Lancet

1989

750

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

Alessandro M. Gianni, Marco Bregni, Salvatore Siena,

New England Journal of Medicine

1997

478

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial

Andrea Gallamini, Francesco Zaja, Caterina Patti,

Blood

2007

307

Graft-Versus-Lymphoma Effect in Relapsed Peripheral T-Cell Non-Hodgkin's Lymphomas After Reduced-Intensity Conditioning Followed by Allogeneic Transplantation of Hematopoietic Cells

Paolo Corradini, Anna Dodero, Francesco Zallio,

Journal of Clinical Oncology

2004

301

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Marco Ladetto, Federica De Marco, Fabio Benedetti,

Blood

2008

253

Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

Paolo Corradini, Claudia Voena, Corrado Tarella,

Journal of Clinical Oncology

1999

242

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

Paolo Corradini, Corrado Tarella, Francesco Zallio,

Leukemia

2006

240

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial

Ralf Ulrich Trappe, Daan Dierickx, Heiner Zimmermann,

Journal of Clinical Oncology

2017

219

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion

Michele Magni, Massimo Di Nicola, Liliana Devizzi,

Blood

2000

217

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani,

Journal of Clinical Oncology

2018

193

Page 1